Treatment of Stage III Cervical Cancer

 

If you have Stage III cervical cancer, you will probably be treated with high-dose internal and external radiation therapy.

  • Internal radiation therapy (brachytherapy) - This technique uses a small pellet of radioactive material placed directly in the vagina near the tumor or placed in the tumor using thin needles. The radioactive material is left in place while you stay in the hospital for 1 to 3 days. This process might be repeated. This treatment is also known as interstitial radiation therapy.
  • External beam radiation therapy (EBRT) - Radiation from outside the body is focused on the cancer. Most people are treated with EBRT 5 days a week for 5 to 7 weeks as an outpatient. This schedule helps protect healthy cells and tissues by spreading out the total dose of radiation.

You will probably also be treated with chemotherapy (cisplatin with or without 5-fluorouracil or other chemotherapy drugs) to increase the effectiveness of radiation therapy.

  • Platinol® (cisplatin) - Cisplatin is a platinum compound chemotherapy drug that acts like an alkylating agent. It stops the growth of cancer cells, causing them to die. Cisplatin is given by an injection into the vein over at least 1 hour. Your dose depends upon the type of cancer you have, your size, and how well your kidneys work.
  • Adrucil ® or Efudex ® (5-fluorouracil or 5-FU) - 5-FU belongs to the group of chemotherapy drugs known as antimetabolites. 5-FU prevents cells from making DNA and RNA, which stops cells from growing. 5-FU is given as a shot in the vein over 5 to 10 minutes, over 20 to 60 minutes, or continuously over 22 to 24 hours for 1 to 4 days or longer. The treatment can be repeated weekly, every other week, or every 3 weeks. The dose depends on your size.

This content has been reviewed and approved by Myo Thant, MD.

 

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Cervical Cancer News
Malaria kills twice as many as thought: study

February 3, 2012 — LONDON (Reuters) - Malaria kills more than 1.2 million people worldwide a year, nearly twice as many as previously thought, according to new research published on Friday that questions years of assumptions about the mosquito-borne disease.

Some girls overestimate HPV vaccine protection

January 2, 2012 — CHICAGO (Reuters) - Some adolescent girls who get the HPV vaccine to prevent cervical cancer wrongly think they no longer need to practice safe sex, U.S. researchers said on Monday.

Study endorses HPV testing for all women over 30

December 15, 2011 — LONDON (Reuters) - New DNA tests looking for the virus responsible for most cases of cervical cancer make sense for all women aged 30 or over, since they can prevent more cases of cancer than Pap smears alone, Dutch researchers said on Thursday.

Select news items provided by Reuters Health